SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-24-006155
Filing Date
2024-01-22
Accepted
2024-01-22 17:27:44
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 424b5_prosup_atm_jan24.htm 424B5 661819
2 GRAPHIC img126483436_0.jpg GRAPHIC 20593
3 GRAPHIC img126483436_1.jpg GRAPHIC 20593
4 GRAPHIC img126483436_2.jpg GRAPHIC 53799
5 GRAPHIC img126483436_3.jpg GRAPHIC 20593
  Complete submission text file 0000950170-24-006155.txt   822625
Mailing Address 30 BROADWICK STREET LONDON X0 W1F 8LX
Business Address 30 BROADWICK STREET LONDON X0 W1F 8LX 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275893 | Film No.: 24549910
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)